We have generated Artificial Neural Networks (ANN) capable of performing sensitive, quantitative predictions of peptide binding to the MHC class I molecule, HLA-A*0204. We have shown that such quantitative ANN are superior to conventional classification ANN, that have been trained to predict binding vs non-binding peptides. Furthermore, quantitative ANN allowed a straightforward application of a 'Query by Committee' (QBC) principle whereby particularly information-rich peptides could be identified and subsequently tested experimentally. Iterative training based on QBC-selected peptides considerably increased the sensitivity without compromising the efficiency of the prediction. This suggests a general, rational and unbiased approach to the development of high quality predictions of epitopes restricted to this and other HLA molecules. Due to their quantitative nature, such predictions will cover a wide range of MHC-binding affinities of immunological interest, and they can be readily integrated with predictions of other events involved in generating immunogenic epitopes. These predictions have the capacity to perform rapid proteome-wide searches for epitopes. Finally, it is an example of an iterative feedback loop whereby advanced, computational bioinformatics optimize experimental strategy, and vice versa. Proteomes are extremely diverse and can be used to ascertain the identity of any organism. This is true even at the level of oligopeptides. Indeed, the immune system has chosen peptides as one of its prime targets. It follows that proteomes can be translated into immunogens once it is known how the immune system generates and handles peptides (1). One of the most selective events is that of peptide binding to MHC. It is therefore important to establish accurate descriptions and predictions of peptide binding to the most common MHC haplotypes.
0.5% of the universe of 9-mer peptides (conversely, more than 99% is ignored) making this one of the most selective events of antigen presentation (3) . However, even 0.5% of the universe of 9-mer peptides is still a sizable number of different peptides (the universe of 9-mer peptides encompasses 5.12 Â 10 11 members; 0.5% of this is 2.56 Â 10 9 ). Such broad peptide binding specificity is achieved through the recognition of so-called 'motifs' representing important requirements needed for binding such as the presence and proper spacing of certain amino acids within the peptide sequence (4) (5) (6) (7) (8) (9) . The most important of these are known as primary anchor residues. In general, there are two to three primary anchor positions and together they constitute a 'simple motif' (reviewed in 9). However, other features such as secondary anchors and disfavored residues, adding up to an 'extended motif', are also important in defining peptide-MHC interaction (8) . The most elaborate extended motifs consist of detailed statistical matrices representing the frequency of every amino acid in every position (10, 11) . Predictions of peptide-MHC binding are usually performed as motif searches, which are far from perfect (12, 13) . A simple motif search has a modest sensitivity; actually, it misses 70% of all binders. An extended motif search has a better sensitivity although it still misses about 30% of all binders (12) ; and the improvement comes at the cost of a large increase in the number of false positives (12) . A likely reason for this lack of efficiency of motif searches is the necessary, but incorrect, assumption that the effect of each amino acid is independent of the sequence context. Although these assumptions may merit considerable justification as an approximation (10) , further improvements in predictions may require that the entire peptide is considered including any sequence specific correlated effects (14) . In addition, it is highly desirable that future prediction schemes are quantitative (15 
Materials and methods

Peptide-MHC class I binding assay
Human MHC-I molecules, HLA-A*0204, were affinity-purified as previously described (25, 26) . Peptides were purchased from Schaefer-N, Copenhagen, or synthesized using a standard FMOCprotection strategy (27) . The purity of the peptides was verified by 
Development of Artificial Neural Networks
The neural networks were of the standard feed-forward type (32) .
Details of sequence encoding, error function, etc. may be found elsewhere (28) . The predictive performance was monitored using the Pearson correlation coefficient during training and testing of the networks. Training was terminated using early stopping (32) .
Redundant sequence data sets were made non-redundant using the first version of the Hobohm procedure (30) . In a sequential scan of the data in a database, this method discards sequences where the similarity in a pair-wise alignment exceeds a given scoring threshold.
The resulting non-redundant data set has therefore no pairs of sequences with a similarity exceeding that threshold. When creating a non-redundant version of SWISS-PROT, a threshold of 25% sequence identity was used. When computing the similarity between 9-mer peptides, the information content in a sequence logo (29) of binders was used to weight the positions in the calculation of the similarity.
Results and discussion
Generating representative sets of quantitative peptide-MHC binding data (primary data selection)
On average, 0.5% of the universe of 9-mer peptides binds MHC with high affinity (3). Consequently, using a random selection strategy, one would have to test 20,000 peptides experimentally to get a mere 100 independent examples of peptide-MHC binding. This is an untenable proposition and mandates a preselection strategy. To test such a selection strategy we used a biochemical peptide-HLA-A*0204 binding assay, which was already available to us (11) . Due to cost and time constraints, all relevant data that were already available were included (peptides from proteins of particular interest such as p53, HSP70, HIV proteins). These were combined with data selected by screening the entire SWISS-PROT database for binders using specificity matrices developed by a previously described combinatorial peptide library approach (11) . This resulted in the identification of more than 100,000 peptides, which were sequence similarity reduced based on The seven unique ANN constructed to predict the binding of 9-mer peptides to HLA-A*0204 were used to cross-validate the approach (Fig. 1) . A highly significant (P < 0.001) correlation between the logarithms of the predicted and observed binding Another notable advantage of the ANN-driven prediction is its ability to predict the exact binding affinity value, whereas the BIMAS prediction is somewhat arbitrary (some of the values are even assigned) and the SYFPEITHI prediction is completely arbitrary (all values are assigned). Thus, the accuracy of the ANN prediction is considerably better than that of the two competing predictions. 
ANN development through successive generations; an iterative process
Although we attempted to select the primary training sets in an unbiased and representative way, the selection process was constrained by the existing data and further shaped by PSCPL-generated matrix predictions (11), i.e., it only involved an infinitely small part of the universe of 9-mer peptides. To counteract these problems, we devised an iterative approach for ANN training and development (34) . An intriguing effect of the QBC principle was found when a complete scanning of the more than 3 million 9-mer peptides extracted from a non-redundant subset of SWISS-PROT was performed. Averaging the predictions of the seven networks in the ensemble, we found that the 1 ANN and the 2 ANN (non--QBC) predicted roughly the same amount %0.25% of all peptides as being very high affinity binders. In contrast, the 2 ANN (QBC) predicted not only these %0.25%, but additionally %0.17%, of all peptides as being very high affinity binders. Thus, the QBC approach was unique in the sense that it suggested the existence of many more high affinity binders. Previous methods have been missing at least one out of three possible binders (12) , and it is tempting to speculate that the QBC approach might account for these missing binders. In that case, this gain in sensitivity could be achieved at minimal expense in terms of the number of false positives. Thus, the QBC principle appears to be an efficient way to improve both the quality and the coverage of ANN.
While this work was in progress (34) were already known at that time (Los Alamos HIV epitopes database þ MHCPEP), 46 (or 82%) had a predicted binding affinity below 500 nM. Thus, using 500 nM as a cut-off we would only have missed 18% of the known epitopes. In contrast, we gained more than 100 hitherto unknown epitope candidates, which met both the requirements of conservation and predicted MHC binding. Of these new putative HIV epitopes, 52 were synthesized and tested for binding; 36 (or 69%) were verified as binders, and the majority of these were recognized in HLA-A2 þ HIV-1 patients (Corbet et al. in press).
Thus, we can project that already the 1 ANN may have more than doubled the number of known HIV-derived, HLA-A*02xx binders and epitopes, and we can expect that further gains will be achieved with the 2 ANN(QBC).
The human MHC project
Taken together, our results suggest that quantitative ANN-driven predictions of peptide-MHC interactions can be generated. Such ANN promise unprecedented high sensitivity (ability to identify positives) and high specificity (ability to reject negatives) predictions.
Our results also suggest a rational iterative approach to generate such ANN and demonstrate the utility of a selective sampling method such as the QBC. It therefore seems reasonable to suggest that this technology could be used to describe and predict human MHC specificities systematically. There are several hundred MHC-I alleles in the human population (36) . One should start with the most common MHC-I; eventually they should all be included. As evolutionary selected variants, we expect that they will differ with respect to their peptide binding specificity and that the corresponding predictions can lead to a more detailed functional description of MHC-I polymorphism.
The long-term goal should be to integrate MHC-I predictions with those of other steps involved in antigen processing and presentation including peptide generation by proteasome digestion (37) (www.cbs.dtu.dk/services/NetChop/), peptide transport by the TAP complex (38) , etc., in effect, simulating the biology of the immune system (1). These bioinformatics tools should be linked to genome/proteome databases enabling genome/proteome-wide searches for epitopes of immunological interest. This would allow scientists and clinicians to examine any organism or protein of interest for the presence of potentially immunogenic epitopes and should provide a rational approach to vaccine development and immunotherapy.
Finally, it should be noted that the iterative QBC approach is an example of how a mutual feedback between computational bioinformatics and experiments (wet biochemistry) can guide each other to achieve optimal performance with the least amount of time and resources invested. A successful integration of computation and experiment might enable the evaluation of every single member of an otherwise unmanageably large sequence space.
The ANN generated in this paper are publicly available at www.cbs.dtu.dk/services/NetMHC/ 
